glp 1 mimetics Frontiers Glucagon-Like Peptide-1 Receptor Agonists–Health Professional

A large international study suggests that a subset of people with Type 2 diabetes carry genetic variants that blunt the effectiveness of widely used GLP-1based drugs, despite unexpectedly elevated levels of the hormone in their bodies

The medication works through a dual mechanism of action

But GLP-1 receptor agonists do more than just help shuttle glucose around your body

Peer review Peer review information Communications Biology thanks Cong Xie and the other, anonymous, reviewer(s) for their contribution to the peer review of this work

Health Qual

However, during clinical trials, researchers observed that these medications also led to significant weight loss in many participants, prompting further studies specifically targeting populations with obesity